CO6862159A2 - Compuesto inhibidor de la señalización de la trayectoria notch - Google Patents

Compuesto inhibidor de la señalización de la trayectoria notch

Info

Publication number
CO6862159A2
CO6862159A2 CO14014585A CO14014585A CO6862159A2 CO 6862159 A2 CO6862159 A2 CO 6862159A2 CO 14014585 A CO14014585 A CO 14014585A CO 14014585 A CO14014585 A CO 14014585A CO 6862159 A2 CO6862159 A2 CO 6862159A2
Authority
CO
Colombia
Prior art keywords
inhibitor compound
signaling inhibitor
path signaling
notch path
notch
Prior art date
Application number
CO14014585A
Other languages
English (en)
Spanish (es)
Inventor
Philip Arthur Hipskind
Gregory Alan Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CO6862159A2 publication Critical patent/CO6862159A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CO14014585A 2011-07-27 2014-01-24 Compuesto inhibidor de la señalización de la trayectoria notch CO6862159A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161512016P 2011-07-27 2011-07-27
US201161560486P 2011-11-16 2011-11-16

Publications (1)

Publication Number Publication Date
CO6862159A2 true CO6862159A2 (es) 2014-02-10

Family

ID=46598983

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14014585A CO6862159A2 (es) 2011-07-27 2014-01-24 Compuesto inhibidor de la señalización de la trayectoria notch

Country Status (36)

Country Link
US (1) US8569286B2 (https=)
EP (1) EP2736920B1 (https=)
JP (1) JP6027110B2 (https=)
KR (1) KR101578309B1 (https=)
CN (1) CN103732612B (https=)
AP (1) AP4080A (https=)
AR (1) AR087107A1 (https=)
AU (1) AU2012287251B2 (https=)
BR (1) BR112014001600B1 (https=)
CA (1) CA2841178C (https=)
CL (1) CL2014000175A1 (https=)
CO (1) CO6862159A2 (https=)
CR (1) CR20140036A (https=)
CY (1) CY1116645T1 (https=)
DK (1) DK2736920T3 (https=)
DO (1) DOP2014000011A (https=)
EA (1) EA023044B1 (https=)
EC (1) ECSP14013179A (https=)
ES (1) ES2544937T3 (https=)
GT (1) GT201400012A (https=)
HR (1) HRP20150771T1 (https=)
HU (1) HUE027534T2 (https=)
IL (1) IL229988A (https=)
JO (1) JO3148B1 (https=)
MA (1) MA35611B1 (https=)
ME (1) ME02171B (https=)
MX (1) MX356536B (https=)
MY (1) MY184303A (https=)
PE (1) PE20141061A1 (https=)
PH (1) PH12014500215B1 (https=)
PL (1) PL2736920T3 (https=)
PT (1) PT2736920E (https=)
RS (1) RS54135B1 (https=)
SI (1) SI2736920T1 (https=)
TW (1) TWI568730B (https=)
WO (1) WO2013016081A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014110506A2 (en) * 2013-01-14 2014-07-17 The Trustees Of Columbia University In The City Of New York Methods of treating, preventing and diagnosing leukemia and other blood diseases and disorders
CN112472699A (zh) 2013-07-26 2021-03-12 种族肿瘤学公司 改善比生群及衍生物的治疗益处的组合方法
TWI704151B (zh) 2014-12-22 2020-09-11 美商美國禮來大藥廠 Erk抑制劑
TWI609687B (zh) 2015-04-14 2018-01-01 美國禮來大藥廠 平滑肌肉瘤之標靶性治療
JO3491B1 (ar) * 2015-07-07 2020-07-05 Audion Therapeutics مركبات مثبطة لإشارات مسار notch
IL287136B2 (en) 2016-02-05 2023-09-01 Denali Therapeutics Inc Receptor inhibitors - interacting with protein kinase 1
ES3057783T3 (en) 2016-03-15 2026-03-04 Oryzon Genomics Sa Combinations of lsd1 inhibitors for use in the treatment of neoplastic diseases
EP3442528B1 (en) * 2016-04-12 2021-05-26 Eli Lilly and Company Combination therapy with notch and pi3k/mtor inhibitors for use in treating ovarian cancer
JP6911047B2 (ja) * 2016-04-12 2021-07-28 イーライ リリー アンド カンパニー がんの処置のための、Notch阻害剤およびCDK4/6阻害剤の併用療法
JP7194022B2 (ja) 2016-05-20 2022-12-21 イーライ リリー アンド カンパニー Notch阻害剤とPD-1またはPD-L1阻害剤との併用療法
SG11201901325UA (en) * 2016-08-31 2019-03-28 Lilly Co Eli Dosage regimen for treatment of solid tumors
EP3525796A1 (en) 2016-10-12 2019-08-21 Eli Lilly and Company Targeted treatment of mature t-cell lymphoma
JP7208137B2 (ja) 2016-12-09 2023-01-18 デナリ セラピューティクス インコーポレイテッド 化合物、組成物および方法
MX2019009552A (es) 2017-02-17 2019-10-02 Hutchinson Fred Cancer Res Terapias de combinacion para el tratamiento de canceres relacionados con el antigeno de maduracion de celulas b (bcma) y trastornos autoinmunitarios.
PT3703750T (pt) 2017-11-01 2025-01-17 Memorial Sloan Kettering Cancer Center Recetores de antigénio quimérico específicos para o antigénio de maturação das células b e polinucleótidos codificantes
MX2020004568A (es) * 2017-11-06 2020-10-05 Juno Therapeutics Inc Combinación de una terapia celular y un inhibidor de gamma secretasa.
KR20210005714A (ko) * 2018-05-06 2021-01-14 아얄라 파마큐티컬즈 아이엔씨. 비스플루오로알킬-1,4-벤조디아제피논 화합물을 포함하는 조합 조성물 및 이의 사용 방법
CA3114113A1 (en) 2018-10-02 2020-04-09 Frequency Therapeutics, Inc. Pharmaceutical compositions and methods related to otic therapeutic agents
US20220175776A1 (en) 2019-04-08 2022-06-09 Frequency Therapeutics, Inc. Combination of chir99021 and valproic acid for treating hearing loss
TW202334164A (zh) 2022-01-12 2023-09-01 美商戴納立製藥公司 (S)-5-苄基-N-(5-甲基-4-側氧基-2,3,4,5-四氫吡啶並[3,2-b][1,4]氧氮呯-3-基)-4H-1,2,4-三唑-3-甲醯胺的晶型

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0001232A3 (en) * 1996-12-23 2001-02-28 Elan Pharmaceuticals Inc San F Cycloalkyl, lactam, lactone derivatives and their thio analogues inhibiting betha-amyloid peptide release and/or its synthesis and pharmaceutical compositions containing the compounds
JP2002518481A (ja) 1998-06-22 2002-06-25 エラン ファーマシューティカルズ,インコーポレイテッド β−アミロイドペプチドの放出および/またはその合成を阻害するための化合物
WO1999067221A1 (en) * 1998-06-22 1999-12-29 Elan Pharmaceuticals, Inc. Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
EP1592684B1 (en) 2003-02-04 2008-07-30 F. Hoffmann-La Roche Ag Malonamide derivatives as gamma-secretase inhibitors
KR100838852B1 (ko) 2003-09-09 2008-06-16 에프. 호프만-라 로슈 아게 감마-세크리테이즈의 활성을 차단하는 말론아미드 유도체
SI1673347T1 (sl) 2003-10-06 2015-10-30 F. Hoffmann - La Roche Ag Substituirani derivati dibenzo-azepina in benzo-diazepina, ki so uporabni kot inhibitorji gama-sekretaze
ES2398531T3 (es) 2006-03-27 2013-03-20 F. Hoffmann-La Roche Ag Derivados de malonamida como inhibidores de gamma secretasa
KR101150574B1 (ko) * 2007-02-02 2012-05-30 에프. 호프만-라 로슈 아게 6-옥소-6,7-다이하이드로-5h-다이벤조[b,d]아제핀-7-일 유도체
MA33076B1 (fr) 2008-01-11 2012-03-01 Hoffmann La Roche Utilisation d'un inhibiteur de la gamma-secretase pour le traitement du cancer
WO2011060051A1 (en) * 2009-11-12 2011-05-19 University Of Massachusetts Methods for treating glioblastoma

Also Published As

Publication number Publication date
EP2736920A1 (en) 2014-06-04
CN103732612A (zh) 2014-04-16
AU2012287251B2 (en) 2015-05-14
JP2014527042A (ja) 2014-10-09
JO3148B1 (ar) 2017-09-20
EP2736920B1 (en) 2015-07-01
HUE027534T2 (en) 2016-11-28
EA201490161A1 (ru) 2014-04-30
AU2012287251A1 (en) 2014-01-30
ECSP14013179A (es) 2014-03-31
AP4080A (en) 2017-03-29
CR20140036A (es) 2014-03-21
AP2014007362A0 (en) 2014-01-31
ME02171B (me) 2015-10-20
ES2544937T3 (es) 2015-09-07
AR087107A1 (es) 2014-02-12
BR112014001600A2 (pt) 2017-02-21
IL229988A (en) 2017-07-31
KR20140026624A (ko) 2014-03-05
BR112014001600B1 (pt) 2022-09-13
JP6027110B2 (ja) 2016-11-16
PE20141061A1 (es) 2014-09-06
CY1116645T1 (el) 2017-03-15
MY184303A (en) 2021-03-31
PT2736920E (pt) 2015-09-16
MX2014001084A (es) 2014-02-27
TW201315732A (zh) 2013-04-16
DK2736920T3 (en) 2015-07-20
CL2014000175A1 (es) 2014-08-22
PH12014500215B1 (en) 2018-09-07
SI2736920T1 (sl) 2015-08-31
CA2841178A1 (en) 2013-01-31
WO2013016081A1 (en) 2013-01-31
CA2841178C (en) 2016-12-20
KR101578309B1 (ko) 2015-12-16
DOP2014000011A (es) 2014-07-31
CN103732612B (zh) 2015-09-23
HRP20150771T1 (hr) 2015-08-28
TWI568730B (zh) 2017-02-01
US8569286B2 (en) 2013-10-29
MA35611B1 (fr) 2014-11-01
PH12014500215A1 (en) 2014-03-17
GT201400012A (es) 2014-07-16
US20130029972A1 (en) 2013-01-31
MX356536B (es) 2018-06-01
NZ618891A (en) 2015-12-24
EA023044B1 (ru) 2016-04-29
RS54135B1 (sr) 2015-12-31
HK1194086A1 (en) 2014-10-10
PL2736920T3 (pl) 2015-11-30

Similar Documents

Publication Publication Date Title
CO6862159A2 (es) Compuesto inhibidor de la señalización de la trayectoria notch
CO6900145A2 (es) Compuesto de ciclopropanoamina
LT2751083T (lt) Kvinolono junginys
CO6930358A2 (es) Compuestos inhibidores de metaloenzimas
CR20140024A (es) Compuestos inhibidores de metaloenzimas
SMT201600308B (it) Composti di benzene arile-o eteroarile-sostituiti
HUE036259T2 (hu) Inhibitor vegyületek
DK2693881T3 (da) Substituerede n-phenylpyrimidin-2-amin-analoger som inhibitorer af axl-kinase
DK2371923T3 (da) Aflejringshæmmer
HRP20181786T1 (hr) Inhibitori aktivacije t-stanica
PL2739628T3 (pl) Nowe makrocykle jako inhibitory czynnika xia
BR112014012159A2 (pt) tetra-hidrocanabivarina fitocanabinóide
CU24164B1 (es) Inhibidores sustituidos de acetil-coa carboxilasa
BR112013023048A2 (pt) composto de guanidina
EP2710007A4 (en) Kinase inhibitors
EP2768399A4 (en) Ligation clip
CO6970602A2 (es) Inhibidores de quinasa
DK2678329T3 (da) Triazolopyridinforbindelser som pim-kinase-hæmmere
EP2877457A4 (en) CYSTATHIONIN-LYASE (CSE) INHIBITORS
EP2695296A4 (en) NON-FOSTER-CIRCUIT
BR112014012016A2 (pt) compostos
CL2014000325A1 (es) Compuestos derivados de piranos sustituidos, implicados en la señalizacion de nematodos
CO6910197A2 (es) Compuestos novedosos
SMT201600328B (it) Nuovi composti come inibitori di diacilglicerolo aciltransferasi
BR112013025761A2 (pt) inibidores de hsp90

Legal Events

Date Code Title Description
FG Application granted